IBM & deCODE link up in gene mining:
This article was originally published in Clinica
IBM's life sciences division has joined forces with Icelandic population genetics firm deCODE genetics to develop gene mining tools. The two companies plan jointly to market deCODE's Clinical Genome Miner Discovery system using IBM hardware and software. While the technology will be marketed to pharmaceutical and biotech firms as well as public research bodies as a drug discovery and research tool, deCODE's expertise in gene variations and disease could have important applications in diagnostics.